article thumbnail

How Digital Patient Intake is Revolutionizing Healthcare

Referral MD

Yet, the healthcare experience often begins with a decidedly analog ritual: The dreaded patient intake form. While medical science advances, too many clinics still rely on cumbersome paperwork. Its simple: Digital patient intake forms. What is Digital Patient Intake? Whats the solution to such an age-old problem?

article thumbnail

How AI Can Help Medical Science Liaisons Juggle Their Ever-Growing Responsibilities

PM360

Traditionally, Medical Affairs has focused on cross-functional collaboration with commercial and R&D teams, medical communication, evidence generation, and dissemination. MSLs are key purveyors of scientific truth and viewed highly by HCPs/KOLs, and they are driven by their passion to help patients.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Improving Patient Outcomes with Immersive Learning

Infuse Medical

In the healthcare Operations field, achieving the best possible patient outcomes is paramount. This means ensuring patients not only understand their diagnosis but are also empowered to participate actively in their treatment plan. It utilizes computer-generated simulations to create realistic and interactive environments.

Patients 130
article thumbnail

The Role of Medical Science Liaisons in The Pharmaceutical Industry

Contrarian Sales Techniques

Are you ready to explore the fascinating world of Medical Science Liaisons (MSLs) in the pharmaceutical industry ? MSLs are considered the experts in scientific and medical information and they are responsible for building relationships with healthcare professionals. The growing demand for MSLs shows no signs of slowing down.

article thumbnail

Artificial Intelligence and Life Expectancy: How AI Will Contribute to Improving Human Health.

MaBiCo

Personalized Medicine Thanks to AI, we will create simulations of the human body at the molecular, cellular and organ levels, allowing treatments to be personalized for each patient. This will lead to treatments that are more effective and safer, as the specificities of each patient will be taken into account.

article thumbnail

Life sciences response to 2024 Autumn Budget

European Pharmaceutical Review

However, the Autumn Budget provides some relief via additional funding for the strained NHS, a welcome outcome considering for example, that “record numbers of cancer patients are having to wait longer than they should to begin their treatment”, explained Naser Turabi, Director of Evidence and Implementation at Cancer Research UK.

article thumbnail

Amgen and Pfizer appoint new Science executives

European Pharmaceutical Review

Academy of Medical Sciences. “I I am honoured to be succeeding [ Dr Mikael Dolsten ] and to be taking on leadership of a combined R&D organisation that includes… a promising pipeline of innovative medicines and vaccines candidates poised to have a tremendous impact for patients globally,” shared Dr Boshoff.